Determining Mechanisms of Response to Polo-like Kinase 1 Inhibition in Non-Small Cell Lung Cancer
R Goonatilake - 2016 - digitalcommons.library.tmc.edu
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death
worldwide. The discovery of genetic alterations in some patients (~ 15%) has made it …
worldwide. The discovery of genetic alterations in some patients (~ 15%) has made it …
Tyrosine kinase signalling pathways in pancreatic cancer
CM Tactacan - 2015 - unsworks.unsw.edu.au
dc. description. abstract Pancreatic cancer (PC) still remains one of the most aggressive and
lethal of human cancers, with a lack of prognostic and predictive biomarkers and effective …
lethal of human cancers, with a lack of prognostic and predictive biomarkers and effective …
[引用][C] Cancer Immunotherapy
R Ajina, D Aldeghaither, S Jablonski, LM Weiner - 2017 - Elsevier
[引用][C] Effects of gefitinib on quality of life and expression of inflammatory cytokines, T cell subsets and serum tumor markers in senile patients with NSCLC.
Y Zhu, J Lv, Y Zhou - Biomedical Research (0970-938X), 2017